Sunday, December 22, 2024
HomeNews

News

Taiwan’s Academab Develops Groundbreaking Therapy for COVID-19 Omicron Variant With Potent Neutralizing Efficacy

Taiwanese biotech outfit AcadeMab has broken new ground in the development of COVID immunotherapies through the development of a potentially life-saving monoclonal antibodies for...

FDA Flexibilities, Collaboration to Yield Millions of Bottles of Specialized Medical Infant Formula in Coming Months to Increase U.S. Supply

The U.S. Food and Drug Administration is providing an update on steps it has taken that will lead to millions of bottles of specialized...

Next-Generation Immunotherapy Drug Shows Continued Promise in Several Advanced-Stage Cancers

Initial study results show that an experimental drug, called nemvaleukin alfa, when used alone or in combination with another anticancer drug (pembrolizumab) may be...

Meridian Bioscience responds to the Monkeypox Outbreak with its Inhibitor-Tolerant qPCR Master Mixes for the Development of Molecular Tests

Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced that its inhibitor-tolerant qPCR master mixes are...

NovoMedix Receives Research Grant from the National Institutes of Health (NIH) to Advance NMX1 in TBNC

NovoMedix, LLC, a biotechnology company creating novel, safe, and effective drugs to treat unmet medical needs, announced that the National Heart, Lung, and Blood...
0FansLike
0FollowersFollow
spot_img

Hot Topics